AEDR
AEDR | Cardiovascular Bioregulator Peptide
DoseGear research brief
Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports tissue repair and improves cardiovascular function, particularly benefiting the heart and blood vessels.
Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, enhances myocardial function, and improves cardiovascular tissue regeneration by influencing gene expression in heart cells.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Khavinson-associated tetrapeptide arising from cardiac-tissue research.
Experimental cardiac-cell regulation and repair through proposed gene-expression and cell-survival effects.
Not reported in the reviewed compound-specific evidence.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Calculation example | 1 mg | See source guide · See source guide | Injectable · 20 mg lyophilized vial + 3 mL BAC Water |
Reference cycle
10-20 days per cycle
Reference storage
Capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Peptide Regulation of Gene Expression: A Systematic Review
Cardiogen Bioregulator Research
Khavinson Peptide Bioregulators Overview
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.
